|
Antibiotic treatment
|
Routine empirical therapy (%)
|
rm-PCR-guided therapy (%)
|
|---|
|
Beta-lactams
|
147 (92)
|
131 (82)
|
|
Third-generation cephalosporin
|
35 (22)
|
24 (15)
|
|
Piperacillin-tazobactam
|
29 (18)
|
34 (21)
|
|
Amoxicillin-clavulanate
|
27 (17)
|
25 (16)
|
|
Carbapenem
|
27 (17)
|
19 (12)
|
|
Cefepime
|
19 (12)
|
19 (12)
|
|
Amoxicillin
|
5 (3)
|
4 (3)
|
|
Ceftazidime
|
3 (2)
|
7 (4)
|
|
Cefazolin
|
2 (1)
|
6 (4)
|
|
Penicillin M
|
0 (0)
|
2 (1)
|
|
Companion molecule
|
79 (50)
|
50 (31)
|
|
Macrolide
|
20 (13)
|
4 (3)
|
|
Metronidazole
|
17 (11)
|
8 (5)
|
|
Aminoglycoside
|
15 (9)
|
19 (12)
|
|
Fluoroquinolone
|
8 (5)
|
5 (3)
|
|
Glycopeptide
|
6 (4)
|
2 (1)
|
|
Linezolide
|
6 (4)
|
8 (5)
|
|
Cotrimoxazole
|
7 (4)
|
4 (3)
|
|
Antifungal therapy
|
5 (3)
|
4 (3)
|
|
Oseltamivir
|
3 (2)
|
0
|
|
Other
|
4 (3)
|
0
|
- Results are presented as n (%)
